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A partial sequence of the NS5 gene showed that the Zika 
virus isolate from this patient was closely related to those 
described elsewhere in the Western Hemisphere belonging 
to the Asian lineage, particularly to 2 strains identified in 
Brazil and Suriname during 2015.
Acknowledgments
We thank the staff of the Molecular Biology and Virology 
Departments, InDRE for technical assistance. We also thank Jose 
Gudiño (Queretaro Public Health Laboratory) for sending serum 
sample for analysis.
The findings and conclusions in this report are those of the  
authors and do not necessarily represent the official opinion of 
the Ministry of Health of Mexico.
References
  1. Musso D, Cao-Lormeau VM, Gubler DJ. Zika virus: following the 
path of dengue and chikungunya? Lancet. 2015;386:243–4   
http://dx.doi.org/10.1016/S0140-6736(15)61273-9. 
  2. Musso D. Zika virus transmission from French Polynesia to 
Brazil. Emerg Infect Dis. 2015;21:1887 http://dx.doi.org/10.3201/
eid2110.151125.
  3. Kuno G, Chang GJ. Full-length sequencing and genomic  
characterization of Bagaza, Kedougou, and Zika viruses. Arch Virol. 
2007;152:687–96. http://dx.doi.org/10.1007/s00705-006-0903-z
  4. Haddow AD, Schuh AJ, Yasuda CY, Kasper MR, Heang V,  
Huy R, et al. Genetic characterization of Zika virus strains: 
geographic expansion of the Asian lineage. PLoS Negl Trop Dis. 
2012;6:e1477 http://dx.doi.org/10.1371/journal.pntd.0001477.
  5. Enfissi A, Codrington J, Roosblad J, Kazanji M, Rousset D. 2016. 
Zika virus genome from the Americas. Lancet. 2016;387:227–8. 
http://dx.doi.org/10.1016/S0140-6736(16)00003-9 
  6. World Health Organization. Zika virus outbreaks in the  
Americas. Wkly Epidemiol Rec. 2015;90:609–10.  
http://www.who.int/wer/2015/wer9045.pdf?ua=1
  7. Centers for Disease Control and Prevention. Zika virus [cited 2016 
Jan 20]. http://www.cdc.gov/zika/
  8. Untergasser A, Nijveen H, Rao X, Bisseling T, Geurts R,  
Leunissen JA. Primer3Plus, an enhanced web interface to Primer3. 
Nucleic Acids Res. 2007;35:W71–4. http://dx.doi.org/10.1093/ 
nar/gkm306
  9. Díaz-Quiñonez JA, Escobar-Escamilla N, Ortíz-Alcántara J, 
Vázquez-Pichardo M, de la Luz Torres-Rodríguez M, Nuñez-León 
A, et al. Identification of Asian genotype of chikungunya virus 
isolated in Mexico. Virus Genes. 2016; 52:127–9.  
http://dx.doi.org/10.1007/s11262-015-1275-9
Address for correspondence: José Alberto Díaz-Quiñonez, Instituto de 
Diagnóstico y Referencia Epidemiológicos “Dr. Manuel Martínez Báez,” 
Francisco de P. Miranda 177, Col. Lomas de Plateros, C. P. 01480, Alvaro 
Obregón, Mexico City, Mexico; email: alberto.diaz@salud.gob.mx
Technological Solutions to 
Address Drug-Resistant  
Neisseria gonorrhoeae
Claire C. Bristow, Huan Dong, Jeffrey D. Klausner
Author affiliations: University of California San Diego, La Jolla, 
California, USA (C.C. Bristow); Charles R. Drew University of 
Medicine and Science, Los Angeles, California, USA (H. Dong); 
University of California Los Angeles, Los Angeles (H. Dong,  
J.D. Klausner)
DOI: http://dx.doi.org/10.3201/eid2205.160083
To the Editor: Since the 1930s, Neisseria gonor-
rhoeae has become resistant to drugs in every class of an-
timicrobial therapy used to treat it. We read with interest 
the article by Martin et al. about trends in Canada on N. 
gonorrhoeae susceptibility to third-generation cephalospo-
rins, the only class of antimicrobial drugs to which most 
N. gonorrhoeae strains remain susceptible (1). We find the 
reported decrease in cefixime- and ceftriaxone-reduced 
susceptibility during 2010–2014 encouraging, but remain 
concerned about a threat from drug-resistant and untreat-
able N. gonorrhoeae infections: a similar downward trend 
in the United States reversed in 2014 (2). That divergence 
demonstrates the limited reliability of surveillance data.
Addressing resistance requires new methods for 
susceptibility determination without culture. Real-time 
screening for genes associated with antimicrobial drug re-
sistance, such as penA mosaic alleles yielding decreased 
susceptibility to oral extended-spectrum cephalosporins, 
may be a valuable method to determine treatment (3). In 
the same issue of Emerging Infectious Diseases, Deguchi et 
al. described a case of multidrug-resistant N. gonorrhoeae 
(4), further highlighting the urgency for the innovative ap-
proach of using molecular tests to individualize treatment 
regimens. An ongoing study supported by the National 
Institutes of Health (R21AI109005) is evaluating how a 
laboratory-developed molecular N. gonorrhoeae genotypic 
susceptibility test for ciprofloxacin enables rapid identifica-
tion of effective antimicrobial drugs (5).
N. gonorrhoeae may acquire new resistance mecha-
nisms under selection pressures imposed by use of antimi-
crobial drugs and horizontal gene transfer from other com-
mensal Neisseria species resident in the human oropharynx 
(3). Inconsistent pharyngeal N. gonorrhoeae screening may 
lead to missed opportunities for treatment. A National In-
stitutes of Health program (Antibiotic Resistance Leader-
ship Group, award no. UM1AI104681) is ongoing to assist 
manufacturers in obtaining US Food and Drug Adminis-
tration approval for molecular assays to detect extragenital 
gonococcal infections.
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For nearly 8 decades, N. gonorrhoeae has been con-
trollable. Continued investment in research and the de-
velopment of new laboratory technology are critical in 
supporting an effective response to mitigate the threat of 
untreatable gonorrhea.
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To the Editor: As an increasing number of autochtho-
nous Zika virus infections are reported from several South 
America countries (1), we read with interest the report from 
Musso et al. on the potential sexual transmission of Zika 
virus (2). We report additional evidence for this potential 
route of transmission after identification of an imported 
case of infection into the United Kingdom.
After an outbreak alert for Zika in French Polynesia, ac-
tive screening was implemented at Public Health England 
(Porton Down, United Kingdom). In 2014, a 68-year-old 
man had onset of fever, marked lethargy, and an erythema-
tous rash 1 week after returning from the Cook Islands. Se-
rum samples taken 3 days into the febrile illness tested nega-
tive for dengue and chikungunya viruses by real-time reverse 
transcription PCR (rRT-PCR). Test results for dengue virus 
IgM and chikungunya virus IgM also were negative; a test 
result for dengue virus IgG was indeterminate.
An rRT-PCR test result for Zika virus (3) was positive 
and indicated a crossing threshold value of 35 cycles. This 
low viral load, commonly observed even in the acute phase 
of disease (3), meant that attempts to obtain sequence data 
were unsuccessful. Convalescent-phase serum, urine, and 
semen samples were requested; only semen was positive 
for by rRT-PCR, at 27 and 62 days after onset of febrile 
illness. These results demonstrated stronger signals than 
those obtained in tests of the original serum sample, 
with crossing threshold values of 29 and 33 cycles, re-
spectively. Zika virus–specific plaque reduction neutral-
ization test results were positive on convalescent-phase 
serum samples.
Although we did not culture infectious virus from se-
men, our data may indicate prolonged presence of virus in 
semen, which in turn could indicate a prolonged potential 
for sexual transmission of this flavivirus. Moreover, these 
findings could inform decisions regarding what control 
methods are implemented and which specimen types are 
best suited for diagnostic detection.
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